Cyclooxygenase (COX)-2 Inhibitors Reduce Toxoplasma Gondii Infection and Upregulate the Pro-Inflammatory Immune Response in Calomys Callosus Rodents and Human Monocyte Cell Line

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2019.00225
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

CCR5 Controls Immune and Metabolic Functions During Toxoplasma Gondii Infection

PLoS ONE
Multidisciplinary
2014English

Comparison of Nonsteroidal Anti-Inflammatory Drugs and Cyclooxygenase-2 (COX-2) Inhibitors Use in Australia and Nova Scotia (Canada)

British Journal of Clinical Pharmacology
Pharmacology
2009English

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Seroepidemiology of Toxoplasma Gondii Infection Among Human Population in Lahore

International Journal of Biosciences (IJB)
2017English

Early Kinetics of Intestinal Infection and Immune Responses to Two Toxoplasma Gondii Strains in Pigs

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2020English

Toxoplasma Gondii: Identification and Immune Response Against a Group of Proteins Involved in Cellular Invasion

Experimental Parasitology
MedicineParasitologyInfectious DiseasesImmunology
2012English

Leptin and Pro-Inflammatory Stimuli Synergistically Upregulate MMP-1 and MMP-3 Secretion in Human Gingival Fibroblasts

PLoS ONE
Multidisciplinary
2016English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy